Study: Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia

(Ohio State University Wexner Medical Center) The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news